Veterinary Intravenous Solutions Market To Reach $2.67 Billion By 2030

Veterinary Intravenous Solutions Market Growth & Trends

The global veterinary intravenous solutions market size is expected to reach USD 2.67 billion by 2030, expanding at a CAGR of 8.37% from 2023 to 2030, according to a new report by Grand View Research, Inc. The growth is driven by increasing awareness of animal welfare, advancements in veterinary healthcare, increasing pet ownership, and the increasing prevalence of illnesses such as anthrax, pancreatitis, and mouth disease. The advancements in veterinary medicine have expanded the range of treatment options available for animals. Veterinary clinics and hospitals are equipped with advanced diagnostic and treatment facilities, including intravenous fluid administration systems, which contribute to the growth of the market.

The development of advanced IV fluid delivery systems designed specifically for veterinary use has made the administration process more efficient, accurate, and safe. These technological advancements, such as specialized infusion pumps and fluid monitoring systems, have positively impacted the veterinary intravenous solutions industry by enhancing patient care and reducing the risk of complications. Rising disposable income levels in many regions have led to increased spending on pet healthcare. Pet owners are more willing to invest in high-quality veterinary care, including intravenous fluid therapy, which contributes to the growth of the market.

The post-COVID-19 impact on the veterinary intravenous solutions industry is still unfolding as the global situation continues to evolve. The COVID-19 pandemic recovery has led to an increased demand for veterinary intravenous solutions as part of the standard care provided to animals during surgeries, treatments, and critical care situations. The economic impact of the pandemic affected many individuals and businesses, including pet owners and veterinary clinics. Financial constraints may have influenced the decision-making process for pet owners, potentially leading to a decrease in non-essential veterinary procedures and treatments, including the use of IV fluids.

Moreover, the adoption of veterinary intravenous (IV) fluid solutions in North America is relatively high due to various factors such as veterinary education programs in North America emphasizing the importance of IV fluid therapy and its appropriate use in different clinical situations. Veterinarians and veterinary technicians receive extensive training in the administration, monitoring, and management of IV fluids, ensuring their competent use in practice. Furthermore, veterinary professionals in North America strive to provide high-quality care for animals. IV fluid therapy is a crucial component of comprehensive veterinary treatment, and its adoption is driven by the commitment to optimize patient care and support the recovery and well-being of animals.

 Request a free sample copy or view report summary: Veterinary Intravenous (IV) Solutions Market Report

Veterinary Intravenous Solutions Market Report Highlights

• Based on product, the isotonic crystalloids segment dominated the market with a share of over 42% in 2022. To restore and maintain hydration and electrolyte balance in animals, fluid therapy in veterinary medicine frequently uses isotonic crystalloid solutions

• Based on animal type, the companion animals segment dominated the market in 2022. Many homes regularly keep companion animals as pets, especially dogs and cats. Pet ownership leads to a large demand for veterinary intravenous solutions, as these animals frequently require intravenous therapy for a variety of health issues, surgeries, or critical care situations

• Based on indication, the Diabetic Ketoacidosis (DKA) segment dominated the market in 2022

• Based on end-use, the veterinary hospital segment dominated the market with a revenue share of over 55% in 2022, as more people are taking their pets to veterinarian facilities for care. IV hydration therapy is frequently used in veterinary hospitals as a crucial part of patient care

• North America held the highest revenue share of over 38.0% of the market in 2022. In North America, there is a high rate of pet ownership, with many homes keeping companion animals like dogs, cats, and small mammals

Veterinary Intravenous Solutions Market Segmentation

Grand View Research has segmented the global veterinary intravenous solutions market based on product, animal type, indication, end-use, and region:

Veterinary IV Solutions Product Outlook (Revenue, USD Million, 2018 - 2030)

• Isotonic Crystalloids

• Synthetic Colloids

• Blood Products

• Dextrose Solutions

• Parenteral Nutrition

Veterinary IV Solutions Indication Outlook (Revenue, USD Million, 2018 - 2030)

• Diabetic Ketoacidosis

• Pancreatitis

• Anthrax

• Chronic Kidney Disease

• Others

Veterinary IV Solutions Animal Type Outlook (Revenue, USD Million, 2018 - 2030)

• Companion Animals

• Production Animals

Veterinary IV Solutions End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Veterinary Hospitals

• Research Institutes

• Others

Veterinary IV Solutions Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

• U.S.

• Canada

• Europe

• UK

• Germany

• France

• Italy

• Spain

• Denmark

• Sweden

• Norway

• Asia Pacific

• Japan

• China

• India

• South Korea

• Australia

• Thailand

• Latin America

• Brazil

• Mexico

• Argentina

• Middle East & Africa

• South Africa

• Saudi Arabia

• UAE

• Kuwait

List of Key Players in the Veterinary Intravenous Solutions Market

• Merck & Co., Inc.

• Dechra Veterinary Products

• Sypharma

• Animalcare

• B. Braun SE

• Woods Consulting, LLC

• Baxter

• Fresenius Kabi